Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat


Autoria(s): EKUNDI-VALENTIM, E.; SANTOS, K. T.; CAMARGO, E. A.; DENADAI-SOUZA, A.; TEIXEIRA, S. A.; ZANONI, C. I.; GRANT, A. D.; WALLACE, J. L.; MUSCARA, M. N.; COSTA, S. K.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Background and purpose: Recent findings suggest that the noxious gas H(2)S is produced endogenously, and that physiological concentrations of H(2)S are able to modulate pain and inflammation in rodents. This study was undertaken to evaluate the ability of endogenous and exogenous H(2)S to modulate carrageenan-induced synovitis in the rat knee. Experimental approach: Synovitis was induced in Wistar rats by intra-articular injection of carrageenan into the knee joint. Sixty minutes prior to carrageenan injection, the rats were pretreated with indomethacin, an inhibitor of H(2)S formation (dl-propargylglycine) or an H(2)S donor [Lawesson`s reagent (LR)]. Key results: Injection of carrageenan evoked knee inflammation, pain as characterized by impaired gait, secondary tactile allodynia of the ipsilateral hindpaw, joint swelling, histological changes, inflammatory cell infiltration, increased synovial myeloperoxidase, protein nitrotyrosine residues, inducible NOS (iNOS) activity and NO production. Pretreatment with LR or indomethacin significantly attenuated the pain responses, and all the inflammatory and biochemical changes, except for the increased iNOS activity, NO production and 3-NT. Propargylglycine pretreatment potentiated synovial iNOS activity (and NO production), and enhanced macrophage infiltration, but had no effect on other inflammatory parameters. Conclusions and implications: Whereas exogenous H(2)S delivered to the knee joint can produce a significant anti-inflammatory and anti-nociceptive effect, locally produced H(2)S exerts little immunomodulatory effect. These data further support the development and use of H(2)S donors as potential alternatives (or complementary therapies) to the available anti-inflammatory compounds used for treatment of joint inflammation or relief of its symptoms.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

BRITISH JOURNAL OF PHARMACOLOGY, v.159, n.7, p.1463-1474, 2010

0007-1188

http://producao.usp.br/handle/BDPI/28169

10.1111/j.1476-5381.2010.00640.x

http://dx.doi.org/10.1111/j.1476-5381.2010.00640.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

British Journal of Pharmacology

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #hydrogen sulphide #synovitis #carrageenan #rat #secondary tactile allodynia #nitric oxide #Lawesson`s reagent #neutrophils #IL-1 beta #NITRIC-OXIDE SYNTHASE #PRIMARY AFFERENT NEURONS #RHEUMATIC-DISEASES #INDUCED ARTHRITIS #KAPPA-B #INFLAMMATION #INHIBITION #CHANNELS #INJURY #EXPRESSION #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion